WeVote

Bill

Bill

SB 2413

RELATING TO MEDICAL CANNABIS.

2026 Regular Session Introduced by Stanley Chang and 5 co-sponsors

Hawaii medical cannabis bill SB 2413 advances with HHS committee approval and amendments, expanding patient access while establishing regulatory oversight for therapeutic use.

The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 4 Aye(s): Senator(s) San Buenaventura, McKelvey, Kanuha, Keohokalole; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Fevella.
0
WeVote Research Nonpartisan
Bill Summary · SB 2413

Legislative bill overview

SB 2413 is a Hawaii medical cannabis bill introduced by multiple legislators that has advanced through the Health and Human Services committee with recommended amendments. The bill was referred to both HHS/CPN and JDC/WAM committees for review, with the HHS committee voting 4-0 in favor of passage with modifications on February 6, 2026.

Why this is important

Medical cannabis policy affects patient access to treatment options, regulatory frameworks for dispensing, state revenue, and healthcare provider participation. Hawaii's approach will influence how the state balances patient needs, law enforcement concerns, and regulated commerce in this evolving area of medicine.

Potential points of contention

  • Scope of qualifying conditions: Disagreement likely exists over which medical conditions justify cannabis use and whether the list should be broad or restrictive
  • Regulatory oversight and equity: Questions about licensing requirements, social equity provisions for communities affected by prior cannabis criminalization, and administrative burden on providers
  • Banking and federal law conflicts: Challenges in accessing financial services and legal clarity given cannabis remains federally scheduled as Schedule I

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.